{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T19:48:11Z","timestamp":1794685691921,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.maturitas.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T02:08:13Z","timestamp":1317002893000},"page":"295-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss"],"prefix":"10.1016","volume":"70","author":[{"given":"Anjali","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillel W.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie E.","family":"Schoenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2011.08.003_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002030-200402200-00014","article-title":"Reduced bone mineral density in HIV-infected women","volume":"18","author":"Dolan","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-005-1845-0","article-title":"Bone mass and mineral metabolism in HIV+ postmenopausal women","volume":"16","author":"Yin","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jinf.2002.1109","article-title":"Osteopenia in HIV-infected women prior to highly active antiretroviral therapy","volume":"46","author":"Teichmann","year":"2003","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.maturitas.2011.08.003_bib0020","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"February (2)","key":"10.1016\/j.maturitas.2011.08.003_bib0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0b013e3181bf6471","article-title":"Short-term bone loss in HIV-infected premenopausal women","volume":"53","author":"Yin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.GME.0000141981.88782.38","article-title":"Menopause symptoms in HIV-infected and drug-using women","volume":"12","author":"Miller","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0035","series-title":"Research on the menopause in the 1990s: report of a WHO scientific working group","author":"World Health Organization","year":"1996"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1176\/ajp.131.10.1121","article-title":"The CAGE questionnaire: validation of a new alcoholism screening instrument","volume":"131","author":"Mayfield","year":"1974","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/aje\/152.2.99","article-title":"Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies, HIVNET Vaccine Preparedness Study Protocol Team","volume":"152","author":"Metzger","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0055","first-page":"1","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of WHO study group","volume":"843","author":"World Health Organization","year":"1994","journal-title":"World Health Org Tech Rep Ser"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0060","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/501015","article-title":"HIV infection and bone mineral density in middle-aged women","volume":"42","author":"Arnsten","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00002030-200107060-00009","article-title":"Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir","volume":"15","author":"Nolan","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.maturitas.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1310\/4X0H-UVMJ-BHYW-CPFB","article-title":"Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients","volume":"4","author":"Fernandez-Rivera","year":"2003","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"November (3)","key":"10.1016\/j.maturitas.2011.08.003_bib0085","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/QAI.0b013e3181893e8e","article-title":"Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study","volume":"49","author":"Jacobson","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"July (12)","key":"10.1016\/j.maturitas.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"INSIGHT SMART Body Composition Substudy group. Continuous antiretroviral therapy decreases bone mineral density","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"},{"issue":"August (5)","key":"10.1016\/j.maturitas.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"May\u2013June (3)","key":"10.1016\/j.maturitas.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1310\/hct0803-164","article-title":"The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-na\u00efve HIV-1-infected patients","volume":"8","author":"Cassetti","year":"2007","journal-title":"HIV Clin Trials"},{"issue":"April (7)","key":"10.1016\/j.maturitas.2011.08.003_bib0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/QAD.0b013e328328f789","article-title":"ANRS 121 Hippocampe study group, Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients","volume":"23","author":"Duvivier","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.maturitas.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"issue":"July (11)","key":"10.1016\/j.maturitas.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","article-title":"First line zidovudine\/lamivudine\/lopinavir\/ritonavir leads to greater bone loss compared to nevirapine\/lopinavir\/ritonavir","volume":"23","author":"van Vonderen","year":"2009","journal-title":"AIDS"},{"issue":"March (5)","key":"10.1016\/j.maturitas.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"issue":"2 Suppl.","key":"10.1016\/j.maturitas.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1086\/375879","article-title":"Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease","volume":"37","author":"Cooper","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0130","doi-asserted-by":"crossref","first-page":"1414.e7","DOI":"10.1016\/j.amjmed.2005.07.033","article-title":"Bone mineral density in subjects using central nervous system-active medications","volume":"118","author":"Kinjo","year":"2005","journal-title":"Am J Med"},{"issue":"December (3)","key":"10.1016\/j.maturitas.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.maturitas.2011.08.003_bib0140","first-page":"42","article-title":"Effects of chronic heroin abuse on bone and mineral metabolism","volume":"129","author":"Pedrazzoni","year":"1993","journal-title":"Acta Endocrinol"},{"issue":"September (9)","key":"10.1016\/j.maturitas.2011.08.003_bib0145","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"July (12)","key":"10.1016\/j.maturitas.2011.08.003_bib0150","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"INSIGHT SMART Body Composition Substudy group, Continuous antiretroviral therapy decreases bone mineral density","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512211002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:53:06Z","timestamp":1759913586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512211002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0378512211002945"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.08.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2011.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}